These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8681156)

  • 1. Cholesterol awareness and treatment in patients with coronary artery disease participating in cardiac rehabilitation.
    Bairey Merz CN; Felando MN; Klein J
    J Cardiopulm Rehabil; 1996; 16(2):117-22. PubMed ID: 8681156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperlipidaemia management after primary coronary artery bypass surgery: a survey of patients and general practitioners.
    Goldsmith I; Lip GY; Emsden K; Nugent A; Patel RL
    J Cardiovasc Risk; 1999 Aug; 6(4):263-7. PubMed ID: 10501279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group.
    Schrott HG; Bittner V; Vittinghoff E; Herrington DM; Hulley S
    JAMA; 1997 Apr 23-30; 277(16):1281-6. PubMed ID: 9109465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
    J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug therapy for hypercholesterolemia in patients with cardiovascular disease: factors limiting achievement of lipid goals.
    Schectman G; Hiatt J
    Am J Med; 1996 Feb; 100(2):197-204. PubMed ID: 8629655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-lowering treatment in hypercholesterolemic patients: the CEPHEUS Thailand survey.
    Sukonthasarn A; Homsanit M; Prommete B; Chotinaiwattarakul C; Piamsomboon C; Likittanasombat K
    J Med Assoc Thai; 2011 Dec; 94(12):1424-34. PubMed ID: 22295727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid lowering in the cardiac rehabilitation setting.
    Ades PA; Savage PD; Poehlman ET; Brochu M; Fragnoli-Munn K; Carhart RL
    J Cardiopulm Rehabil; 1999; 19(4):255-60. PubMed ID: 10453433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emphasis on high-density lipoprotein cholesterol in patients with coronary artery disease.
    Mailander L; Lavie CJ; Milani RV; Gaudin D
    South Med J; 1993 May; 86(5):508-12. PubMed ID: 8488395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of a physician-directed treatment program for low-income patients with high blood cholesterol: the Southeast Cholesterol Project.
    Keyserling TC; Ammerman AS; Davis CE; Mok MC; Garrett J; Simpson R
    Arch Fam Med; 1997; 6(2):135-45. PubMed ID: 9075448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-lowering treatment in coronary artery disease: how low should cholesterol go?
    Jones PH
    Drugs; 2000 May; 59(5):1127-35. PubMed ID: 10852644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise-induced vasomotion of angiographically normal and stenotic coronary arteries improves after cholesterol-lowering drug therapy with bezafibrate.
    Seiler C; Suter TM; Hess OM
    J Am Coll Cardiol; 1995 Dec; 26(7):1615-22. PubMed ID: 7594094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achieving optimal lipid goals in patients with coronary artery disease.
    Karalis DG; Subramanya RD; Hessen SE; Liu L; Victor MF
    Am J Cardiol; 2011 Mar; 107(6):886-90. PubMed ID: 21247526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000.
    Ford ES; Mokdad AH; Giles WH; Mensah GA
    Circulation; 2003 May; 107(17):2185-9. PubMed ID: 12719276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coaching patients with coronary heart disease to achieve the target cholesterol: a method to bridge the gap between evidence-based medicine and the "real world"--randomized controlled trial.
    Vale MJ; Jelinek MV; Best JD; Santamaria JD
    J Clin Epidemiol; 2002 Mar; 55(3):245-52. PubMed ID: 11864795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efficacy of the lipid-lowering armamentarium: the clinical benefits of aggressive lipid-lowering therapy.
    Hunninghake DB
    Am J Med; 1998 Feb; 104(2A):9S-13S. PubMed ID: 9550501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional survey.
    Primatesta P; Poulter NR
    BMJ; 2000 Nov; 321(7272):1322-5. PubMed ID: 11090516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achieving National Cholesterol Education Program goals for low-density lipoprotein cholesterol in cardiac patients: importance of diet, exercise, weight control, and drug therapy.
    Allison TG; Squires RW; Johnson BD; Gau GT
    Mayo Clin Proc; 1999 May; 74(5):466-73. PubMed ID: 10319076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of lipid-lowering therapy in multiple risk factor management.
    Esper RJ
    Drugs; 1998; 56 Suppl 1():1-7; discussion 33. PubMed ID: 9740535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.